Variant report
Variant | nsv946068 |
---|---|
Chromosome Location | chr1:91999761-92000913 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562425456 | chr1:91999767-91999768 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374799460 | chr1:91999806-91999807 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533097607 | chr1:91999813-91999814 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551157837 | chr1:91999842-91999843 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs594834 | chr1:91999853-91999854 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs190816181 | chr1:91999855-91999856 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370243247 | chr1:91999874-91999875 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374485352 | chr1:91999883-91999884 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146317764 | chr1:91999891-91999892 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535461158 | chr1:91999897-91999898 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551031449 | chr1:91999908-91999909 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138433165 | chr1:91999967-91999968 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182770418 | chr1:92000034-92000035 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558337310 | chr1:92000136-92000137 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142920409 | chr1:92000152-92000153 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188090096 | chr1:92000285-92000286 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7543267 | chr1:92000297-92000298 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7527073 | chr1:92000307-92000308 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146117717 | chr1:92000331-92000332 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7536077 | chr1:92000337-92000338 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555147589 | chr1:92000428-92000429 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573713077 | chr1:92000431-92000432 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7543372 | chr1:92000440-92000441 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543795498 | chr1:92000479-92000480 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112113485 | chr1:92000569-92000570 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555786926 | chr1:92000570-92000571 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577465796 | chr1:92000576-92000577 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544908597 | chr1:92000586-92000587 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs383486 | chr1:92000690-92000691 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560257524 | chr1:92000712-92000713 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547824865 | chr1:92000769-92000770 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12759236 | chr1:92000804-92000805 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs420999 | chr1:92000812-92000813 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562028290 | chr1:92000818-92000819 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566483223 | chr1:92000829-92000830 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372620278 | chr1:92000830-92000831 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529453002 | chr1:92000832-92000833 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191850765 | chr1:92000875-92000876 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113458668 | chr1:92000880-92000881 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 16397240 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Prostate cancer | 19156837 | CNVD |
Autism | 17483303 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:91967800-92009600 | Weak transcription | Thymus | Thymus |
2 | chr1:91983000-92002600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr1:91985000-92000400 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr1:91989400-92002800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr1:91990800-92000800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr1:91994600-92002200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
7 | chr1:91995400-92002200 | Weak transcription | NHDF-Ad | bronchial |
8 | chr1:91995400-92002400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr1:91995800-92001200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
10 | chr1:91995800-92003000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr1:91996000-92002800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
12 | chr1:91997800-92000400 | Enhancers | Primary T cells fromperipheralblood | blood |
13 | chr1:91998600-92000800 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
14 | chr1:91998600-92001200 | Strong transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr1:91999200-92002800 | Weak transcription | Fetal Heart | heart |
16 | chr1:91999200-92005800 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
17 | chr1:92000400-92001200 | Weak transcription | Primary T cells fromperipheralblood | blood |